Flu

GSK tests swine flu vaccine

Human trials of its swine flu vaccine have begun, says GlaxoSmithKline.

The company plans to conduct 16 clinical trials of the vaccine in more than 9,000 people in Europe, Canada and the United States. Early results from the first trial in Germany are expected to be available in September, the Associated Press reported.

The findings will be shown to drug regulatory agencies in order to hasten their decisions about whether to approve the vaccine. Fast-track approval systems for swine flu vaccines have been created in Europe and the United States.

Earlier this month, Novartis and Sanofi-aventis began testing their swine flu vaccines, the AP reported. – (HealthDay News, August 2009)

Read more:
SA: swine flu map
World: swine flu map

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Voting Booth
Have you entered our Health of the Nation survey?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes
32% - 9467 votes
No
68% - 20230 votes
Vote